202 related articles for article (PubMed ID: 31130961)
1. Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes.
Barcenilla H; Åkerman L; Pihl M; Ludvigsson J; Casas R
Front Immunol; 2019; 10():982. PubMed ID: 31130961
[TBL] [Abstract][Full Text] [Related]
2. FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.
Viisanen T; Gazali AM; Ihantola EL; Ekman I; Näntö-Salonen K; Veijola R; Toppari J; Knip M; Ilonen J; Kinnunen T
Front Immunol; 2019; 10():19. PubMed ID: 30723474
[TBL] [Abstract][Full Text] [Related]
3. Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets.
Magnusson L; Barcenilla H; Pihl M; Bensing S; Espes D; Carlsson PO; Casas R
Front Immunol; 2020; 11():288. PubMed ID: 32153591
[TBL] [Abstract][Full Text] [Related]
4. A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients.
Oras A; Peet A; Giese T; Tillmann V; Uibo R
Clin Exp Immunol; 2019 Oct; 198(1):57-70. PubMed ID: 31116879
[TBL] [Abstract][Full Text] [Related]
5. Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.
Haller MJ; Gitelman SE; Gottlieb PA; Michels AW; Perry DJ; Schultz AR; Hulme MA; Shuster JJ; Zou B; Wasserfall CH; Posgai AL; Mathews CE; Brusko TM; Atkinson MA; Schatz DA
Diabetes; 2016 Dec; 65(12):3765-3775. PubMed ID: 27669730
[TBL] [Abstract][Full Text] [Related]
6. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
Ly D; Mi QS; Hussain S; Delovitch TL
J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
[TBL] [Abstract][Full Text] [Related]
7. CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.
Brenu EW; Bartley TJ; Wright CM; Hamilton-Williams EE
Immunol Cell Biol; 2017 Oct; 95(9):803-813. PubMed ID: 28611472
[TBL] [Abstract][Full Text] [Related]
8. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
[TBL] [Abstract][Full Text] [Related]
9. Identity and Diversity of Human Peripheral Th and T Regulatory Cells Defined by Single-Cell Mass Cytometry.
Kunicki MA; Amaya Hernandez LC; Davis KL; Bacchetta R; Roncarolo MG
J Immunol; 2018 Jan; 200(1):336-346. PubMed ID: 29180490
[TBL] [Abstract][Full Text] [Related]
10. [Immune changes in type 1 diabetes animal model after syngeneic bone marrow transplantation].
Lü CL; Ouyang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):726-30. PubMed ID: 20561438
[TBL] [Abstract][Full Text] [Related]
11. Genetic association of HLA DQB1 with CD4+CD25+(high) T-cell apoptosis in type 1 diabetes.
Glisic S; Klinker M; Waukau J; Jailwala P; Jana S; Basken J; Wang T; Alemzadeh R; Hagopian W; Ghosh S
Genes Immun; 2009 Jun; 10(4):334-40. PubMed ID: 19295543
[TBL] [Abstract][Full Text] [Related]
12. Circulating T helper and T regulatory subsets in untreated early rheumatoid arthritis and healthy control subjects.
Pandya JM; Lundell AC; Hallström M; Andersson K; Nordström I; Rudin A
J Leukoc Biol; 2016 Oct; 100(4):823-833. PubMed ID: 27190305
[TBL] [Abstract][Full Text] [Related]
13. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
Jaberi-Douraki M; Pietropaolo M; Khadra A
J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
[TBL] [Abstract][Full Text] [Related]
14. NK cells and type 1 diabetes.
Rodacki M; Milech A; de Oliveira JE
Clin Dev Immunol; 2006; 13(2-4):101-7. PubMed ID: 17162353
[TBL] [Abstract][Full Text] [Related]
15. Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.
Hamari S; Kirveskoski T; Glumoff V; Kulmala P; Simell O; Knip M; Veijola R
Scand J Immunol; 2016 Apr; 83(4):279-87. PubMed ID: 26888215
[TBL] [Abstract][Full Text] [Related]
16. A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetes.
Waid DM; Wagner RJ; Putnam A; Vaitaitis GM; Pennock ND; Calverley DC; Gottlieb P; Wagner DH
Clin Immunol; 2007 Aug; 124(2):138-48. PubMed ID: 17560173
[TBL] [Abstract][Full Text] [Related]
17. Exhausted-like CD8+ T cell phenotypes linked to C-peptide preservation in alefacept-treated T1D subjects.
Diggins KE; Serti E; Muir V; Rosasco M; Lu T; Balmas E; Nepom G; Long SA; Linsley PS
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351781
[TBL] [Abstract][Full Text] [Related]
18. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic Analysis of Human Lymph Nodes in Subjects With New-Onset Type 1 Diabetes and Healthy Individuals by Flow Cytometry.
Yang JHM; Khatri L; Mickunas M; Williams E; Tatovic D; Alhadj Ali M; Young P; Moyle P; Sahni V; Wang R; Kaur R; Tannahill GM; Beaton AR; Gerlag DM; Savage COS; Napolitano Rosen A; Waldron-Lynch F; Dayan CM; Tree TIM
Front Immunol; 2019; 10():2547. PubMed ID: 31749806
[No Abstract] [Full Text] [Related]
20. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
Åkesson K; Tompa A; Rydén A; Faresjö M
Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
